For ovarian cancer, women with BRCA1 PV have a cumulative lifetime risk of 44 % (95% CI 36–53), whereas BRCA2 PV carriers carry a risk of 17% (95% CI 11–25) [2]. The gene discussed is BRCA1; the disease is ovarian cancer.